Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective
- PMID: 36705888
- PMCID: PMC9943834
- DOI: 10.1007/s13300-022-01355-4
Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective
Abstract
Keeping up with the global scenario, diabetes prevalence is on rise in India. Inadequate glycemic control is a major cause of diabetes-related morbidity and mortality. The conventional standards of care (SOC) in diabetes, including self-monitoring of blood glucose and measurement of glycated hemoglobin, have supported achievement of glycemic control, yet there are a few limitations. With the use of current technologies and metrics, such as continuous glucose monitoring (CGM) and standardized CGM data reporting, the continuous real-time glucose levels can be measured, and importantly, the percentage of time above, below, and within the target glucose range can be calculated, which facilitates patient-centric care, a current goal in diabetes management. International consensus recommendations endorse the incorporation of CGM and CGM data reporting in SOC for diabetes management. The guidelines provide time in range (TIR) thresholds for different patient populations and different types of diabetes. However, extrapolation of these global guidelines does not aptly cover the Indian population, which has diverse diet, culture, and religious practices. In this context, a consensus meeting was held in India in 2021 with experts in the field of diabetes care. The purpose of the meeting was to develop consensus recommendations for TIR thresholds for different patient profiles in India. Those expert recommendations, together with an evidence-based review, are reported here. The aim of this agreement is to aid clinicians across India to routinely use CGM and CGM data reports for optimizing individualized diabetes care, by implementing clinical targets for TIR.
Keywords: Consensus recommendations; Continuous glucose monitoring; Elderly; Gestational diabetes mellitus; Pregnancy; Time in range(s); Type 1 diabetes mellitus; Type 2 diabetes mellitus.
© 2023. The Author(s).
Figures
Similar articles
-
Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes.J Diabetes Sci Technol. 2023 Sep;17(5):1326-1336. doi: 10.1177/19322968221088601. Epub 2022 Apr 26. J Diabetes Sci Technol. 2023. PMID: 35470692 Free PMC article. Review.
-
Research progress in the application of time in range: more than a percentage.Chin Med J (Engl). 2023 Mar 5;136(5):522-527. doi: 10.1097/CM9.0000000000002582. Chin Med J (Engl). 2023. PMID: 36939244 Free PMC article.
-
Individualization of recommendations from the international consensus on continuous glucose monitoring-derived metrics in Japanese children and adolescents with type 1 diabetes.Endocr J. 2020 Oct 28;67(10):1055-1062. doi: 10.1507/endocrj.EJ20-0193. Epub 2020 Jun 20. Endocr J. 2020. PMID: 32565500
-
How to take action beyond ambulatory glucose profile: Latin American expert recommendations on CGM data interpretation.Diabetol Metab Syndr. 2025 May 8;17(1):149. doi: 10.1186/s13098-025-01702-y. Diabetol Metab Syndr. 2025. PMID: 40340929 Free PMC article. Review.
-
Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C).Postgrad Med. 2021 Apr;133(3):253-264. doi: 10.1080/00325481.2020.1851946. Epub 2020 Dec 14. Postgrad Med. 2021. PMID: 33315495
Cited by
-
Metabolic health tracking using Ultrahuman M1 continuous glucose monitoring platform in non- and pre-diabetic Indians: a multi-armed observational study.Sci Rep. 2024 Mar 18;14(1):6490. doi: 10.1038/s41598-024-56933-2. Sci Rep. 2024. PMID: 38499685 Free PMC article.
-
Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on "time in range" in patients with type 2 diabetes.Front Pharmacol. 2024 Mar 7;15:1370594. doi: 10.3389/fphar.2024.1370594. eCollection 2024. Front Pharmacol. 2024. PMID: 38515845 Free PMC article.
-
Enhancing the Impact of Individualized Nutrition Therapy with Real-Time Continuous Glucose Monitoring Feedback in Overweight and Obese Individuals with Prediabetes.Nutrients. 2024 Nov 22;16(23):4005. doi: 10.3390/nu16234005. Nutrients. 2024. PMID: 39683399 Free PMC article. Clinical Trial.
-
Knowledge, attitude, and practice toward postoperative self-management among kidney transplant recipients.BMC Med Educ. 2024 Jun 11;24(1):652. doi: 10.1186/s12909-024-05631-8. BMC Med Educ. 2024. PMID: 38862944 Free PMC article.
-
Assessment of Correlation Between Glycaemic Variability Indices and Measures of Hypoglycaemia in Patients with Type 2 Diabetes Mellitus.Indian J Endocrinol Metab. 2024 Sep-Oct;28(5):522-528. doi: 10.4103/ijem.ijem_469_23. Epub 2024 Nov 8. Indian J Endocrinol Metab. 2024. PMID: 39676789 Free PMC article.
References
-
- International Diabetes Federation. Diabetes Atlas 9th Edition. 2019. https://www.diabetesatlas.org/en/. Accessed 04 May 2021.
-
- Chawla M, Saboo B, Jha S, et al. Consensus and recommendations on continuous glucose monitoring. J Diabetol. 2019;10:4–14. doi: 10.4103/jod.jod_45_18. - DOI
Publication types
LinkOut - more resources
Full Text Sources